Clinical trial

A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-Small Cell Lung Cancer

NCT07830342

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Cyclophosphamid Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Fludarabine Normalized identity: fludarabineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Interleukin 2 subcutaneous injection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Clinical Study of HS-IT101 Injection in Patients With Advanced Non-Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-21

PhasePHASE1

Conditions

Advanced NSCLCunresolved

Interventions

CyclophosphamidDRUG

FludarabineDRUG · verified · RxNorm: fludarabine

Interleukin 2 subcutaneous injectionDRUG

Sponsors & collaborators

Hangzhou Huasai Biomedicine Co., Ltd.lead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07830342 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.